Liver cancer: Biomarker landscape

Emmanuel Kwaku Ofori; Dziedzorm Wormenor

doi:10.1016/B978-0-443-33902-8.00017-1

Liver cancer: Biomarker landscape

Emmanuel Kwaku Ofori, Dziedzorm Wormenor

Department of Chemical Pathology

Paradise Diagnostic Centre

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Liver cancer is a prevalent form of cancer that impacts millions of people globally and contributes significantly to cancer-related deaths. Biomarkers, identifiable indicators of biological activities in the bloodstream, have emerged as a viable technique for enhancing the diagnosis and prediction of liver cancer. This chapter provides a comprehensive analysis of the current status of biomarker research in liver cancer, along with the potential implications for future advancements in the detection and treatment of liver cancer. This chapter also emphasizes the ongoing difficulties when utilizing biomarkers in therapeutic contexts.

Original language	English
Title of host publication	Biomarker Landscape in Cancer Research
Publisher	Elsevier
Pages	1-23
Number of pages	23
ISBN (Electronic)	9780443339028
ISBN (Print)	9780443339035
DOIs	https://doi.org/10.1016/B978-0-443-33902-8.00017-1
Publication status	Published - 1 Jan 2025

Keywords

Alpha-fetoprotein
Biomarker
Chemiluminescent
Genomic
Hepatitis
Immunoassay
Liver cancer
Osteopontin

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-443-33902-8.00017-1

Cite this

@inbook{ac47eb81a9f2433b8ad158fe7ea12d6c,

title = "Liver cancer: Biomarker landscape",

abstract = "Liver cancer is a prevalent form of cancer that impacts millions of people globally and contributes significantly to cancer-related deaths. Biomarkers, identifiable indicators of biological activities in the bloodstream, have emerged as a viable technique for enhancing the diagnosis and prediction of liver cancer. This chapter provides a comprehensive analysis of the current status of biomarker research in liver cancer, along with the potential implications for future advancements in the detection and treatment of liver cancer. This chapter also emphasizes the ongoing difficulties when utilizing biomarkers in therapeutic contexts.",

keywords = "Alpha-fetoprotein, Biomarker, Chemiluminescent, Genomic, Hepatitis, Immunoassay, Liver cancer, Osteopontin",

author = "Ofori, \{Emmanuel Kwaku\} and Dziedzorm Wormenor",

year = "2025",

month = jan,

day = "1",

doi = "10.1016/B978-0-443-33902-8.00017-1",

language = "English",

isbn = "9780443339035",

pages = "1--23",

booktitle = "Biomarker Landscape in Cancer Research",

publisher = "Elsevier",

}

TY - CHAP

T1 - Liver cancer

T2 - Biomarker landscape

AU - Ofori, Emmanuel Kwaku

AU - Wormenor, Dziedzorm

PY - 2025/1/1

Y1 - 2025/1/1

N2 - Liver cancer is a prevalent form of cancer that impacts millions of people globally and contributes significantly to cancer-related deaths. Biomarkers, identifiable indicators of biological activities in the bloodstream, have emerged as a viable technique for enhancing the diagnosis and prediction of liver cancer. This chapter provides a comprehensive analysis of the current status of biomarker research in liver cancer, along with the potential implications for future advancements in the detection and treatment of liver cancer. This chapter also emphasizes the ongoing difficulties when utilizing biomarkers in therapeutic contexts.

AB - Liver cancer is a prevalent form of cancer that impacts millions of people globally and contributes significantly to cancer-related deaths. Biomarkers, identifiable indicators of biological activities in the bloodstream, have emerged as a viable technique for enhancing the diagnosis and prediction of liver cancer. This chapter provides a comprehensive analysis of the current status of biomarker research in liver cancer, along with the potential implications for future advancements in the detection and treatment of liver cancer. This chapter also emphasizes the ongoing difficulties when utilizing biomarkers in therapeutic contexts.

KW - Alpha-fetoprotein

KW - Biomarker

KW - Chemiluminescent

KW - Genomic

KW - Hepatitis

KW - Immunoassay

KW - Liver cancer

KW - Osteopontin

UR - https://www.scopus.com/pages/publications/105011240762

U2 - 10.1016/B978-0-443-33902-8.00017-1

DO - 10.1016/B978-0-443-33902-8.00017-1

M3 - Chapter

AN - SCOPUS:105011240762

SN - 9780443339035

SP - 1

EP - 23

BT - Biomarker Landscape in Cancer Research

PB - Elsevier

ER -

Liver cancer: Biomarker landscape

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this